Literature DB >> 14646519

Intraepithelial lymphocytes vs. colorectal neoplastic cells: who is winning the apoptotic battle?

C A Rubio1.   

Abstract

Intraepithelial lymphocytes (IELs) and Intraepithelial apoptotic granules (AGs) are found in the vast majority of colorectal adenomas, less frequently in incipient carcinomas and occasionally in advanced colorectal carcinomas. In colorectal adenomas, the activated and cytotoxic IELs undergo apoptosis by a Fas-FasL mechanism. In advanced invasive carcinomas lacking IELs, that mechanism cannot be activated. On the other hand, the peritumoural lymphocytes which surround some advanced invasive carcinomas may abrogate to-be-metastatic tumor cells, as treated cancer patients with peritumoural lymphocytes have a better 5-years' survival than those without that peritumoural barrier. In colorectal adenomas the host reaction (IELs) dysplastic cells Fas-dependent confrontation seems to prevent rapidly proliferating adenomas from becoming rapidly invasive carcinomas, since that process takes 10 to 20 years to evolve.

Entities:  

Year:  1997        PMID: 14646519     DOI: 10.1023/a:1026430313275

Source DB:  PubMed          Journal:  Apoptosis        ISSN: 1360-8185            Impact factor:   4.677


  4 in total

1.  The Fas-FasL system and colorectal tumours.

Authors:  C A Rubio; B Jacobsson
Journal:  J Clin Pathol       Date:  2002-07       Impact factor: 3.411

2.  Morphologic and molecular events at the invading edge of colorectal carcinomas.

Authors:  Carlos A Rubio
Journal:  Int J Clin Exp Pathol       Date:  2008-01-01

3.  Adenoma-infiltrating lymphocytes (AILs) are a potential marker of hereditary nonpolyposis colorectal cancer.

Authors:  Alexandros D Polydorides; Bhramar Mukherjee; Stephen B Gruber; Barbara J McKenna; Henry D Appelman; Joel K Greenson
Journal:  Am J Surg Pathol       Date:  2008-11       Impact factor: 6.394

4.  Apoptosis in human tumours.

Authors:  C A Rubio
Journal:  Br J Cancer       Date:  2002-05-20       Impact factor: 7.640

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.